Plasma high sensitivity C-reactive protein and its relationship with cytokine levels in children with newly diagnosed type 1 diabetes and ketoacidosis

Clinical Biochemistry

Volumn 45, Issue 16-17, 2012, Pages 1383-1388

  Karavanaki, Kyriaki ^a   Kakleas, Kostas ^a   Georga, Soultana ^a   Bartzeliotou, Anastasia ^b   Mavropoulos, George ^c   Tsouvalas, Manolis ^a   Vogiatzi, Alice ^c   Papassotiriou, Ioannis ^b   Karayianni, Christina ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b AGHIA SOPHIA CHILDREN S HOSPITAL   (Greece)

^c PENTELI CHILDREN S HOSPITAL   (Greece)

Author keywords

Capillary perturbation; Children; Diabetic ketoacidosis; Hs CRP; IL 6; Severe DKA complications

Indexed keywords

C REACTIVE PROTEIN; CYTOKINE; HIGH SENSITIVITY C REACTIVE PROTEIN; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; CHILD; CLINICAL ARTICLE; CORRELATIONAL STUDY; DIABETIC KETOACIDOSIS; DISEASE SEVERITY; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LEUKOCYTE COUNT; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCHOOL CHILD;

ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; BRAIN EDEMA; C-REACTIVE PROTEIN; CHILD; CHILD, PRESCHOOL; CYTOKINES; DIABETES MELLITUS, TYPE 1; DIABETIC KETOACIDOSIS; FEMALE; HUMANS; LEUKOCYTE COUNT; MALE; PULMONARY EDEMA; STATISTICS, NONPARAMETRIC;

EID: 84868303162     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2012.05.003     Document Type: Article

References (41)

1. Atkinson M.A., Eisenbarth G.S. Type 1 diabetes: new perspectives on disease pathogenesis and treatment. Lancet 2001, 358:221-229.
2. Levitsky L., Ekwo E., Goselink C., Solomon I. Aceto TaPRA. Death from diabetes (DM) in hospitalized children (1970-1988). Pediatr Res 1991, 29:A195.
3. Hoffman W.H., Burek C.L., Waller J.L., Fisher L.E., Khichi M., Mellick L.B. Cytokine response to diabetic ketoacidosis and its treatment. Clin Immunol 2003, 108:175-181.
4. Hoffman W.H., Locksmith J.P., Burton E.M., Hobbs E., Passmore G.G., Pearson-Shaver A.L. Interstitial pulmonary edema in children and adolescents with diabetic ketoacidosis. J Diabetes Complications 1998, 12:314-320.
5. Hoffman W.H., Steinharr C.M., el Gammal T., Steele S., Cuadrado A.R., Morse P.K. Cranial CT in children and adolescents with diabetic ketoacidosis. Am J Neuroradiol 1988, 9:733-739.
6. Durr J.A., Hoffman W.H., Sklar A.H., el Gammal T., Steinhart C.M. Correlates of brain edema in uncontrolled IDDM. Diabetes 1992, 41:627-632.
7. Glaser N., Barnett P., McCaslin I., Nelson D., Trainor J., Louie J., et al. Risk factors for cerebral edema in children with diabetic ketoacidosis. N Engl J Med 2001, 344:264-269.
8. Karavanaki K., Karanika E., Georga S., Bartzeliotou A., Tsouvalas M., Konstantopoulos I., et al. Cytokine response to diabetic ketoacidosis in children with type 1 diabetes. Endocr J 2011, 58:1045-1053.
9. Yudkin J.S., Kumari M., Humphries S.E., Mohamed-Ali V. Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?. Atherosclerosis 2000, 148:209-214.
10. Gogos C.A., Giali S., Paliogianni F., Dimitracopoulos G., Bassaris H.P., Vagenakis A.G. Interleukin-6 and C-reactive protein as early markers of sepsis in patients with diabetic ketoacidosis or hyperosmosis. Diabetologia 2001, 44:1011-1014.
11. Rodriguez-Gaspar M., Santolaria F., Jarque-Lopez A., Gonzalez-Reimers E., Milena A., de la Vega M.J., et al. Prognostic value of cytokines in SIRS general medical patients. Cytokine 2001, 15:232-236.
12. Esposito K., Nappo F., Marfella R., Giugliano G., Giugliano F., Ciotola M., et al. Inflammatory cytokine concentrations are acutely increased by hyperglycaemia in humans: role of oxidative stress. Circulation 2002, 106:2067-2072.
13. Dalton R.R., Hoffman W.H., Passmore G.G., Martin L.A. Plasma C-reactive protein levels in severe diabetic ketoacidosis. Ann Clin Lab Sci 2003, 33:435-441.
14. Cucullo L., Marchi N., Marroni M., Fazio V., Namura S., Janigro D. Blood-brain barrier damage includes release of alpha2-macroglobulin. Mol Cell Proteomics 2003, 2:234-241.
15. Oshima T., Laroux F.S., Coe L.L., Morise Z., Kawachi S., Bauer P., et al. Interferon-gamma and interleukin-10 reciprocally regulate endothelial junction integrity and barrier function. Microvasc Res 2001, 61:130-143.
16. Lagrand W.K., Visser C.A., Hermens W.T., Niessen H.W., Verhengt F.W., Wolbink G.J., et al. C-reactive protein as a cardiovascular risk factor: more than an epiphenomenon?. Circulation 1999, 100:96-102.
17. Galve-de Rochemonteix B., Wiktorowicz K., Kushner I., Dayer J.M. C-reactive protein increases production of IL-1 alpa, IL-1 beta, and TNF-alpha and expression of m-RNA by human alveolar macrophages. J Leukoc Biol 1993, 53:439-445.
18. Pasceri V., Willerson J.T., Yeh E.T. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 2000, 102:2165-2168.
19. Póvoa P., Coelho L., Almeida E., Fernandes A., Mealha R., Moreira P., et al. C-reactive protein as a marker of infection in critically ill patients. Clin Microbiol Infect 2005, 11:101-108.
20. Nahum E., Livni G., Schiller O., Bitan S., Ashkenazi S., Dagan O. Role of C-reactive protein velocity in the diagnosis of early bacterial infections in children after cardiac surgery. J Intensive Care Med May 11 2011, [Epub ahead of print].
21. Pezzilli R., Melzi d'Eril G.V., Morselli-Labate A.M., Merlini G., Barakat B., Bosoni T. Serum amyloid A, procalcitonin, and C-reactive protein in early assessment of severity of acute pancreatitis. Dig Dis Sci 2000, 45:1072-1078.
22. Burke A.P., Tracy R.P., Kolodgie F., Malcom G.T., Zieske A., Kutys R., et al. Elevated C-reactive protein values and atherosclerosis in sudden coronary death. Circulation 2002, 105:2019-2023.
23. American Proficiency Institute 3rd Test Event-American Society for Clinical Pathology (ASCP) 2005.
24. Ciarla M.V., Bocciarelli A., Di Gregorio S., et al. Autoantibodies and endothelial dysfunction in well-controlled, uncomplicated insulin-dependent diabetes mellitus patients. Atherosclerosis 2001, 158:241-246.
25. Asegaonkar S.B., Marathe A., Tekade M.L., Cherekar L., Bavikar J., Bardapurkar J., et al. High-sensitivity C-reactive protein: a novel cardiovascular risk predictor in type 2 diabetics with normal lipid profile. J Diabetes Complications 2011, 25:368-370.
26. Faucher G., Guenard F., Bouchard L., Garneau V., Turcot V., Houde A., et al. Genetic contribution to C-reactive protein levels in severe obesity. Mol Genet Metab Dec 2 2011, [Epub ahead of print].
27. ISPAD Consensus Guidelines 2000 for the management of Type 1 Diabetes Mellitus in children and adolescents. In: Swift PGF, editor. Medical Forum International Publ., Zeist, Netherlands, pp. 14-70.
28. Stentz F.B., Umpierrez G.E., Cuervo R., Kitabchi A.E. Proinflammatory cytokines, markers of cardiovascular risks, oxidative stress, and lipid peroxidation in patients with hyperglycemic crises. Diabetes 2004, 53:2079-2086.
29. Morohoshi M., Fujisawa K., Uchimura I., Numano F. Glucose dependent interleukin 6 and tumour necrosis factor production by human peripheral blood monocytes in vitro. Diabetes 1996, 45:954-959.
30. O'Riordain M.G., Ross J.A., Fearon K.C., Maingay J., Farouk M., Garden O.J., et al. Insulin and counterregulatory hormones influence acute-phase protein production in human hepatocytes. Am J Physiol 1995, 269:E323-E330.
31. Ohta T., Saku K., Takata K., Adachi N. Soluble vascular cell-adhesion molecule-1 and soluble intercellular adhesion molecule-1 correlate with lipid and apolipoprotein risk factors for coronary artery disease in children. Eur J Pediatr 1999, 158:592-598.
32. Campos S.P., Baumann H. Insulin is a prominent modulator of the cytokine-stimulated expression of acute-phase plasma protein genes. Mol Cell Biol 1992, 12:1789-1797.
33. Takala A., Jousela I., Olkkola K.T., Jansson S.E., Leirisalo-Repo M., Takkunen O., et al. Systemic inflammatory response syndrome without systemic inflammation in acutely ill patients admitted to hospital in a medical emergency. Clin Sci 1999, 96:287-295.
34. Hansen T.K., Thiel S., Wouters P.J., Christiansen J.S., Van den Berghe G. Intensive insulin therapy exerts antiinflammatory effects in critically ill patients and counteracts the adverse effect of low mannose-binding lectin levels. J Clin Endocrinol Metab 2003, 88:1082-1088.
35. Dandona P., Chaudhuri A., Ghanim H., Mohanty P. Anti-inflammatory effects of insulin and the pro-inflammatory effects of glucose. Semin Thorac Cardiovasc Surg 2006, 18:293-301.
36. Rosa J.S., Flores R.L., Oliver S.R., Pontello A.M., Zandivar F.P., Galassetti P.R. Sustained IL-1a, IL-4, and IL-6 elevations following correction of hyperglycaemia in children with type 1 diabetes mellitus. Pediatr Diabetes 2008, 9:9-16.
37. Das U.N. Insulin: an endogenous cardioprotector. Curr Opin Crit Care 2003, 9:375-383.
38. Aljada A., Saadeh R., Assian E., Ghanim H., Dandona P. Insulin inhibits the expression of intercellular adhesion molecule-1 by human aortic endothelial cells through stimulation of nitric oxide. J Clin Endocrinol Metab 2000, 85:2572-2575.
39. Tinsley J.H., South S., Chiasson V.L., Mitchell B.M. Interleukin-10 reduces inflammation, endothelial dysfunction and blood pressure in hypertensive pregnant rats. Am J Physiol Integr Comp Physiol 2010, 298:R713-R719.
40. Matsumoto K., Ohi H., Kanmatsuse K. Interleukin 10 and interleukin 13 synergize to inhibit vascular permeability factor release by peripheral blood mononuclear cells from patients with lipoid nephrosis. Nephron 1997, 77:212-218.
41. Singh U., Devaraj S., Dasu M.R., Ciobanu D., Reusch J., Jialal I. C-reactive protein decreases interleukin-10 secretion in activated human monocyte-derived macrophages via inhibition of cyclic AMP production. Arterioscler Thromb Vasc Biol 2006, 26:2469-2475.